A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with Gram-negative urosepsis

Journal of Endotoxin Research

Volumn 6, Issue 1, 2000, Pages 25-31

  Luchi, Michael ^a   Morrison, David C ^b   Opal, Steven ^c   Yoneda, Ken ^d   Slotman, Gus ^e   Chambers, Henry ^f   Wiesenfeld, Harold ^g   Lemke, Jon ^h   Ryan, John L ⁱ   Horn, David ^j  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b ST LUKE S HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Department of Anesthesiology   (United States)

^f SAN FRANCISCO GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ PFIZER INC   (United States)

^j BRISTOL MYERS SQUIBB   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; ENDOTOXIN; IMIPENEM; INTERLEUKIN 6; INTERLEUKIN 8; PENICILLIN BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; URINARY TRACT INFECTION;

ANIMALIA; BACILLI; BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0033949218     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/09680519000060010401     Document Type: Article

References (13)

1. Dofferhoff AS, Nijland JH, de Vries Hospers HG, Mulder PO, Weits J, Bom VJ. Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in vitro and in vivo study. Scand J Infect Dis 1991; 23: 745-754.
2. Jackson JJ, Kropp H. β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 1992; 165: 1033-1041.
3. Dofferhoff AS, Esselink MT, de Vries Hospers HG et al. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J Antimicrob Chemother 1993; 31: 373-384.
4. Arditi M, Kabat W, Yogev R. Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. J Infect Dis 1993; 167: 240-244.
5. Mustafa MM, Mertsola J, Ramilo O, Saez Llorens X, Risser RC, McCracken GHJ. Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. J Infect Dis 1989; 160: 891-895.
6. Mustafa MM, Ramilo O, Mertsola J et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis 1989; 160: 818-825.
7. Odio CM, Faingezicht I, Paris M et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991; 324: 1525-1531.
8. Bucklin SE, Morrison DC. Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of Gram-negative sepsis. J Infect Dis 1995; 172: 1519-1527.
9. Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJ, Speelman P. Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886-891.
10. Suffredini AF, Fromm RE, Parker MM et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321: 280-287.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
12. Simpson AJ, Opal SM, Prins JM, White J, Palardy J. Differential antibiotic-induced endotoxin release in acute septicemic melioidosis. Abstracts of the 38th ICAAC 1998; 597.
13. Maury E, Barakett V, Blanchard H et al. Circulating endotoxin during initial antibiotic treatment of severe gram-negative bacteremic infections. J Infect Dis 1998; 178: 270-273.